Drs. Benjamin Brooks, Carolinas HealthCare System, and Nazem Atassi, Massachusetts General Hospital, provide an overview on two active, Phase 2 clinical trials of Ibudilast in subjects with ALS and discuss how their study teams are collaborating to evaluate the efficacy of MN-166.
